Nitroso Derivative of Prucalopride Impurity A
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Nitroso Derivative of Prucalopride Impurity A

● Auf Lager

Katalog-Nr.::VE0010531
CAS-Nr.::N/A
Summenformel::C14H17ClN4O3
Molare Masse::324.8 g/mol

Zusätzliche Informationen zu Nitroso Derivative of Prucalopride Impurity A

Parent drug

Prucalopride

IUPAC-Name

4-Amino-5-chloro-N-(1-nitrosopiperidin-4-yl)-2, 3-dihydrobenzofuran-7-carboxamide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

Smile

O=C(C1=C(OCC2)C2=C(N)C(Cl)=C1)NC3CCN(N=O)CC3

InChI

InChI=1S/C14H17ClN4O3/c15-11-7-10(13-9(12(11)16)3-6-22-13)14(20)17-8-1-4-19(18-21)5-2-8/h7-8H,1-6,16H2,(H,17,20)

Beschreibung

Nitroso Derivative of Prucalopride Impurity A is an N-nitroso derivative of the secondary amine | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of API and raw material production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url